Evercore ISI Trims Azenta (NASDAQ:AZTA) Target Price to $60.00

Azenta (NASDAQ:AZTA) had its price objective cut by equities researchers at Evercore ISI from $64.00 to $60.00 in a research report issued on Thursday, Benzinga reports. The brokerage currently has an “in-line” rating on the stock. Evercore ISI’s price target would indicate a potential upside of 4.38% from the stock’s previous close.

Other research analysts have also issued reports about the stock. Needham & Company LLC restated a “buy” rating and issued a $75.00 price objective on shares of Azenta in a research note on Thursday, March 28th. B. Riley lifted their price objective on shares of Azenta from $61.00 to $79.00 and gave the company a “buy” rating in a research note on Thursday, February 1st. Stephens restated an “equal weight” rating and issued a $70.00 price objective on shares of Azenta in a research note on Thursday, February 8th. Finally, Jefferies Financial Group assumed coverage on shares of Azenta in a research note on Thursday. They issued a “hold” rating and a $64.00 price objective on the stock. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $69.60.

Azenta Price Performance

Shares of NASDAQ:AZTA opened at $57.48 on Thursday. The company’s fifty day moving average price is $63.06 and its 200 day moving average price is $58.57. Azenta has a 12 month low of $36.01 and a 12 month high of $69.16. The firm has a market capitalization of $3.21 billion, a P/E ratio of -185.41 and a beta of 1.53.

Azenta (NASDAQ:AZTA) last announced its quarterly earnings results on Wednesday, February 7th. The company reported $0.02 EPS for the quarter. The firm had revenue of $154.32 million for the quarter, compared to analyst estimates of $151.86 million. Azenta had a negative net margin of 2.92% and a positive return on equity of 0.49%. On average, sell-side analysts anticipate that Azenta will post 0.28 EPS for the current year.

Institutional Trading of Azenta

A number of institutional investors have recently added to or reduced their stakes in the stock. Thrivent Financial for Lutherans boosted its holdings in Azenta by 0.9% during the third quarter. Thrivent Financial for Lutherans now owns 19,855 shares of the company’s stock worth $851,000 after buying an additional 183 shares in the last quarter. Retirement Systems of Alabama boosted its holdings in Azenta by 0.3% during the fourth quarter. Retirement Systems of Alabama now owns 75,339 shares of the company’s stock worth $4,908,000 after buying an additional 230 shares in the last quarter. Headlands Technologies LLC boosted its holdings in Azenta by 35.6% during the fourth quarter. Headlands Technologies LLC now owns 883 shares of the company’s stock worth $58,000 after buying an additional 232 shares in the last quarter. IMA Wealth Inc. lifted its holdings in shares of Azenta by 0.6% in the second quarter. IMA Wealth Inc. now owns 39,535 shares of the company’s stock valued at $1,845,000 after purchasing an additional 232 shares in the last quarter. Finally, Covestor Ltd lifted its holdings in shares of Azenta by 17.5% in the third quarter. Covestor Ltd now owns 1,714 shares of the company’s stock valued at $86,000 after purchasing an additional 255 shares in the last quarter. Hedge funds and other institutional investors own 99.08% of the company’s stock.

Azenta Company Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.